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Abstract
Background: Measures of population-level influenza severity are important for public health planning, but estimates
are often based on case-fatality and case-hospitalization risks, which require multiple data sources, are prone to
surveillance biases, and are typically unavailable in the early stages of an outbreak. To address the limitations of
traditional indicators, we propose a novel severity index based on influenza age dynamics estimated from routine
physician diagnosis data that can be used retrospectively and for early warning.
Methods: We developed a quantitative ‘ground truth’ severity benchmark that synthesizes multiple traditional
severity indicators from publicly available influenza surveillance data in the United States. Observing that the age
distribution of cases may signal severity early in an epidemic, we constructed novel retrospective and early warning
severity indexes based on the relative risk of influenza-like illness (ILI) among working-age adults to that among school-
aged children using weekly outpatient medical claims. We compared our relative risk-based indexes to the composite
benchmark and estimated seasonal severity for flu seasons from 2001–02 to 2008–09 at the national and state levels.
Results: The severity classifications made by the benchmark were not uniquely captured by any single contributing
metric, including pneumonia and influenza mortality; the influenza epidemics of 2003–04 and 2007–08 were correctly
identified as the most severe of the study period. The retrospective index was well correlated with the severity
benchmark and correctly identified the two most severe seasons. The early warning index performance varied, but it
projected 2007–08 as relatively severe 10 weeks prior to the epidemic peak. Influenza severity varied significantly
among states within seasons, and four states were identified as possible early warning sentinels for national severity.
Conclusions: Differences in age patterns of ILI may be used to characterize seasonal influenza severity in the United
States in real-time and in a spatially resolved way. Future research on antigenic changes among circulating viruses,
pre-existing immunity, and changing contact patterns may better elucidate the mechanisms underlying these
indexes. Researchers and practitioners should consider the use of composite or ILI-based severity metrics in addition
to traditional severity measures to inform epidemiological understanding and situational awareness in future seasonal
outbreaks.
Keywords: Influenza, Influenza-like illness, Severity, Metrics, Age patterns, Epidemiology, Mortality, United States
Background
The causes and characterization of population-level
severity are crucial aspects to understanding influenza
epidemiology and designing effective surveillance and
control programs. Variation in seasonal influenza sever-
ity may be caused by environmental [1, 2], antigenic [3],
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strain-dependent [4], and epidemiological [5] factors, but
this research has not been synthesized across fields and
the mechanisms are not fully understood.
Current discourse about population-level seasonal
influenza severity ties itself traditionally to experiences of
severe patient-level outcomes. The United States Centers
for Disease Control and Prevention (CDC) character-
izes seasonal severity through influenza-associated hos-
pitalization rates and mortality due to pneumonia and
influenza (Fig. 1). From these surveillance data, CDC esti-
mated a range of 3,000 to 49,000 influenza-associated
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Fig. 1 Influenza surveillance data in the United States for the 1997–98 to 2013–14 seasons (excluding 2009–10). Characterization of ILI activity as a
function of: a ILI as a percentage of all outpatient visits in CDC’s ILINet and IMS Health medical claims data, b influenza subtype samples and
percentage of laboratory-confirmed influenza specimens, c laboratory-confirmed influenza surveillance: cumulative hospitalization rates per
100,000 population for ages 5–17 and 18–49, and cumulative pediatric deaths (under 18 years old) over the course of the season, and d number of
deaths attributed to pneumonia and influenza. The grey vertical line denotes a break in the time series for the period from October 2009 through
September 2010; data not shown were not available. e The benchmark (βs) was constructed from surveillance data on positive percentage of
influenza tests, hospitalization rates, pediatric deaths, and pneumonia and influenza deaths. Bar color corresponds to severity categories,
qualitatively assigned in a textual analysis of CDC Flu Season Summaries
Lee et al. BMC Infectious Diseases  (2015) 15:587 Page 3 of 11
all-cause deaths and over 200,000 hospitalizations per
year in the United States during the period between 1976
and 2007 [6, 7]. Clinical studies similarly focus on patient-
level outcomes, where physicians use scoring techniques
to rate overall patient severity or the severity of specific
symptoms [8, 9].
Many epidemiological analyses utilize aggregate mea-
sures of patient-level severity, such as case-fatality and
case-hospitalization risk, to assess the severity of pan-
demic and emerging outbreaks [10–14]. Other studies
model the relationship between excess mortality andmor-
bidity rates [15, 16] or threshold excess pneumonia and
influenza (P&I) mortality rates in order to identify and
detect severe flu seasons. The CDC has recently adopted
a population-level severity framework for influenza pan-
demics that incorporates both clinical severity and trans-
missibility metrics, but the clinical severity component
remains closely tied to case-fatality and similar ratios [12].
These measures of severity based on mortality and hospi-
talization only capture one facet of the experience of flu
across the population [4, 17], and are also limited by the
availability of data. P&I mortality data are not collected
in real-time by many national flu surveillance systems
(e.g., in the European Union), and laboratory-confirmed
hospitalization and mortality data that are collected are
available with some delays (e.g., U.S. hospitalization data
are backfilled due to data processing times) and for lim-
ited age groups (e.g., only laboratory-confirmed pediatric
mortality is reported in the U.S.). Additionally, while hos-
pitalization and mortality remain the accepted measures
of influenza severity, there is no composite quantitative
metric (used by the CDC or others) that synthesizes the
varying acute effects imposed by the disease.
In this work, we develop novel severity assessment met-
rics that synthesize traditional severity measures on viral
activity, hospitalizations, and deaths in the United States,
and explore how the age patterns in influenza-like-illness
(ILI) among the healthiest and largest segments of the
population (children and working-age adults) may be used
as proxies of population-level severity. Based on publicly-
available epidemiological data, we first derive a composite
benchmark that will serve as a quantitative ground truth
for population-level influenza severity. Using a high cov-
erage outpatient ILI dataset based on medical claims data
from the United States, we then introduce two novel
influenza severity metrics: 1) a retrospective index based
on ILI age dynamics, which can aid in epidemiological
analysis and the evaluation of public health responses
using a commonly collected single data source; 2) an
early warning index, estimated prior to the epidemic peak,
which can help physicians improve patient-level commu-
nication, diagnosis, and treatment and inform decision
makers on communication strategies regarding vaccina-
tion and antiviral usage.
Methods
Severity benchmark for each influenza season
We first created a synthetic composite benchmark for each
season to represent a quantitative ‘gold standard’ indi-
cator of severity. This benchmark integrated the follow-
ing publicly available CDC surveillance data, aggregated
to the flu season level: 1) percentage of influenzaposi-
tive laboratory confirmations among all tested respiratory
specimens, 2) laboratory-confirmed influenza hospital-
ization rates among individuals five to seventeen years
old and 3) eighteen to forty-nine years old, 4) number of
laboratory-confirmed influenza deaths in children under
18 years, and 5) proportion of all deaths due to pneu-
monia and influenza (P&I) (time series displayed for the
period from 1997–98 to 2013–14 in Fig. 1b-d). Data for
items one through four may be accessed online through
CDC’s FluView Interactive application [18]; data for item
five may be accessed through the CDC WONDER Mor-
bidity and Mortality Weekly Report web application [19].
Historically, CDC has used these surveillance sources to
qualitatively consider multiple facets of influenza season
severity. CDC’s outpatient ILI surveillance system ILINet
(Fig. 1a), was another such historical source of severity,
but it was excluded from the benchmark in order to pre-
vent confounding when comparing the benchmark to an
ILI-based severity index.
We generated a composite benchmark value for each flu
season (βs, where s denotes the season) for the 16 sea-
sons from 1997–98 to 2013–14 (excluding the 2009 H1N1
pandemic), which represented the entire period that CDC
provided public surveillance data for flu. First, we per-
formed a log transformation to the rate and count data
streams (i.e., hospitalization rates, pediatric deaths) and a
logit transformation to proportion and percent data (i.e.,
positive lab confirmations, P&I deaths) in order to put the
various data types on the same scale. Second, we stan-
dardized each of these ‘raw’ metrics (θi,s, where i denotes
the data stream and s denotes the season) by the mean
(μθi ) and standard deviation (σθi ) across all available flu
seasons, such that θ∗i,s = (θi,s − μθi)/σθi , where * denotes





to generate the compos-






where nθ is the number of contributing data streams.
Larger values of βs indicate more severe seasons according
to the benchmark, and vice versa.
Surveillance systems did not contribute to βs when
data were unavailable (Additional file 1: Table S2).
Alternative standardization periods were considered in
sensitivity analysis; the rank order of seasons accord-
ing to βs was mildly sensitive to these methodological
changes andmay be appropriate for severity assessment in
different research contexts (Additional file 1: Figure S2).
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For comparison, we determined categorical severity
classifications (i.e., mild, moderate, severe) from a qual-
itative analysis of CDC influenza season summaries and
Morbidity and Mortality Weekly Reports. This method
is further described in Additional file 1: Section 3.1 and
Additional file 2. These severity categories were used to
provide additional context to Fig. 1e and Fig. 3.
ILI medical claims data
The primary data for the remainder of our analysis com-
prised weekly physicians’ office and outpatient visits from
October 2001 to May 2009 for influenza-like illness from
a records-level database of CMS-1500 U.S. medical claims
(Fig. 1a). This medical claims dataset incorporated 934
three-digit physician office U.S. zipcode prefixes (zip3s)
and physician coverage increased from 22 to 70% over
the course of the study period; data were collected from
408,606 of 581,876 active physician practices during the
2008–09 flu season. We used a synthetic ILI indicator to
represent influenza activity; this indicator was derived and
validated in a previous study from a set of International
Classification of Diseases, Ninth Revision (ICD-9) codes –
influenza (487–488) or [fever and (respiratory symptoms
or febrile viral illness) (780.6 and (462 or 786.2))] or pre-
scription of oseltamivir (most commonly, 079.99) [20].
Recent analysis finds that ILI claims data accurately cap-
ture weekly fluctuations in influenza activity and season
level intensity at high resolutions by age group and geo-
graphic location [20] and can be used to monitor the
spatial spread of the disease [21]. See Additional file 1: SM
section S1 for statements on ethics and data access. We
considered the population of school-age children as 5–19
years old and working-age adults as 20–59 years old. Data
were adjusted for differences in temporal coverage and
age-specific care-seeking behavior. See Additional file 1:
SM section S2 for further details on ILI data processing.
Retrospective and early warning severity indexes based
on ILI
Based on results from exploratory analysis (see Additional
file 1: SM section S4), our first step towards developing
a severity index was to calculate the relative risk (RR) of
adjusted ILI (see Additional file 1: SM section S2) among
adults to that in school-aged children: RRs(t) = As(t)/Cs(t),
where As(t) and Cs(t) are the number of ILI cases cap-
tured in the surveillance system in a given week (t) in
a season (s), divided by the group’s population size, in
adults and school-age children, respectively (Additional
file 1: Figure S6a). Since ILI is not restricted to laboratory-
confirmed flu cases and baseline ILI activity varies from
year to year, we standardized each season’s weekly RR time
series (rhos(t)), such that ρs(t) = (RRs(t)−μRRs )/σRRs , where
μRRs and σRRs were the mean and standard deviation
of RRs(t) values during a specified baseline period. We
defined this baseline period as the beginning of October
to mid-November (weeks 40–46).
Two severity classification periodswere identified under
our framework, the retrospective (r) and early warning
(w) periods. These periods were the only weeks t when
ρs(t) was significantly correlated with βs, which indicated
the uniqueness of the signal detection during these peri-
ods. See Additional file 1: Section 5.1 and Additional
file 1: Figure S4 for further detail on the identification of
these periods. The retrospective period was the two week
period that began three weeks before the ILI peak in a
given flu season ILI curve; this period can only be identi-
fied retrospective to the epidemic peak. The early warning
period was the two week period that began two weeks
after the Thanksgiving holiday in the United States. We
defined retrospective severity (ρs,r) as the mean of ρs(t)
values during the retrospective period and early warning
severity (ρs,w) as the mean of ρs(t) values during the early
warning period.
Retrospective severity captured the disease dynamics
of the primary epidemic growth period and could only
be assessed after the epidemic peak had passed, while
the early warning severity provided an earlier assessment
of severity between the Thanksgiving and winter holi-
days. Severity was also reasonably well estimated with the
age-specific ILI relative risk over the entire flu epidemic
period, but use of the two-week retrospective period was
preferred as it requires less data (Additional file 1: Figure
S5). Early warning severity was not reported for early flu
seasons (eg. 2003–04) because the early warning period
coincided with the epidemic peak during this season.
To compare βs to ρs,r or ρs,w, we calculated Pearson’s
R correlation coefficients (Ho : R = 0) and reported
p-values from a two-sided test of permutations with-
out replacement.We also compared retrospective severity
to traditional severity metrics, circulation of H3 strains,
vaccine match and vaccine efficacy for seasons where
these data were publicly available from CDC or reported
in other studies [22] (Additional file 1: SM section S5).
The primary analysis constructed and validated indexes
developed from the medical claims ILI data, but a sec-
ondary analysis applied the same methods to construct
relative-risk-based indexes from publicly available data
from CDCŠs ILINet, and compared βs to these relative-
risk-based indexes, ρcdcs,r and ρcdcs,w (Additional file 1:
SM section S8).
We assessed the sensitivity of the retrospective sever-
ity rank order to baseline period duration and found that
the retrospective severity index was somewhat sensitive
to changing baseline periods (Additional file 1: Figure
S6b-d), but that our chosen period best represents base-
line age dynamics (Additional file 1: Figure S7). We
also performed analyses with ILI rates in excess of a
seasonal baseline, and found that age dynamic patterns of
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relative risk remained similar for the medical claims data
(Additional file 1: Figure S8).
State-level analyses
To study regional patterns in influenza severity, we cal-
culated relative-risk-based severity indexes for each U.S.
state with the available, aggregated zip3-level data (See
Additional file 1: SM section S6). State-level retrospec-
tive severity (ρs,r(τ )) and early warning severity (ρs,w(τ )),
where states are represented as τ , were calculated with
similar methods to national level indexes. The state-
level retrospective period was tied to a state’s peak ILI
week. (For example, in season s, California’s retrospective
severity (ρs,r(τ )) is the two week period beginning three
weeks before California’s peak ILI week). In these analyses,
national retrospective and early warning indexes remain
notated ρs,r and ρs,w, respectively.
State-level retrospective severity was examined for each
season. To identify states that may have had more severe
or mild seasons relative to the rest of the United States,
we calculated the state deviation from the national base-
line as the relative difference between state and national
retrospective indexes: ((ρs,r(τ ) − ρs,r)/|ρs,r|). To identify
possible “sentinel” states for national influenza severity,
we compared Pearson’s R correlation coefficients (Ho :
R = 0) between state-level early warning (ρs,w(τ )) and
national retrospective severity (ρs,r) across seven study
seasons (excludes 2003–04, where the early warning
period occurred after the epidemic start). Tests across
states were treated as independent, and p-values were




The composite severity benchmark (βs) identified 1997–
98, 2000–01, 2002–03, 2005–06, 2006–07, and 2011–12
as the mildest seasons and 1999-00, 2003–04, 2010–
11, and 2012–13 as the most severe seasons across the
period from 1997–98 to 2013–14 (excludes the 2009–
10 pandemic year) (Fig. 1e). While the peak percent-
age of influenza-positive test samples appeared higher
among the most severe seasons, this data stream did
not differentiate the mildest from the more moderate
seasons (Fig. 1b). Laboratory-confirmed hospitalization
rates and pediatric deaths varied across seasons, and
only in more recent years (2010–14) did these measures
appear to match benchmark severity magnitude (Fig. 1c).
Peak P&I mortality was greatest among three of the four
most severe seasons according to the benchmark, but
the mildest and more moderate seasons had less clear
separation.
Benchmark severity magnitude was not uniquely cap-
tured by any single contributing metric, supporting our
use of a composite benchmark measure (Fig. 1b-d and
Additional file 1: Figure S1). For example, the 2006–
07 season was one of the mildest seasons according to
the benchmark, and it had the lowest rates of child and
adult hospitalization and P&Imortality compared to other
seasons, but relatively high counts in pediatric deaths,
suggesting that seasons could have mixed indications of
severity across different data streams. More severe sea-
sons like 1999-00, 2003–04, and 2012–13 tended to have
high P&I mortality at the peak, but they did not nec-
essarily have a greater percentage of influenza-positive
laboratory tests. Moreover, high P&I mortality was not a
sufficient condition to indicate severity, as demonstrated
by the severe 2010–11 season. In comparing the data
across seasons, the benchmark integrated these indica-
tors into a single quantitative value that captured the
magnitude of these multiple facets of severity.
Measuring severity through age-specific illness risks
We were motivated to study ILI age patterns for epidemi-
ological and empirical reasons. While elderly and young
child populations are considered high-risk for severe
influenza outcomes and are the traditional source of direct
measurements of influenza severity, we adopted an indi-
rect approach by considering ILI rates in high transmis-
sion age groups: adults and children. Children are thought
to play an important role in influenza transmission due
to high numbers of contacts [23, 24], while working-age
adults represent a large part of the population, bridge con-
tact between age groups, and have greater within-group
contact heterogeneity [24, 25]. We operationalized this
relationship by using weekly ILI data (Fig. 2a) to consider
a weekly proxy of age-specific disease burden, ρs(t), which
is a standardized relative risk of adult to child ILI rates at
week t (Fig. 2b). We emphasize that our metric is not a
proxy for seasonal transmissibility; rather, it is formulated
from the relative age distribution of cases.
We compared our relative risk-based severity measures
(retrospective ρs,r and early warning ρs,w) with quantita-
tive classifications such as the benchmark (βs) and other
traditional severity metrics. During the 2001–02 to 2008–
09 study period, retrospective severity (ρs,r) identified
2002–03, 2006–07, and 2008–09 as the mildest seasons
and 2003–04 and 2007–08 as the most severe seasons.
Retrospective severity was moderately correlated with the
benchmark (Pearson’s R = 0.71, p-value = 0.05 when
compared to βs classifications) (Fig. 3a). The early warn-
ing index (ρs,w) projected 2007–08 as relatively severe and
2002–03 and 2006–07 as relatively mild; the correlation
was weaker with the benchmark (Pearson’s R = 0.59, p-
value = 0.16) (Fig. 3b). Note that the 2003–04 season
was removed from this analysis because it peaked dur-
ing the early warning period (Fig. 2a). Among traditional
severity metrics, total season ILI visits also had a positive
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Fig. 2 Influenza age dynamics differ from overall epidemic dynamics. aMedically attended outpatient ILI visits per 100,000 for the 2001–02 through
2008–09 flu seasons, adjusted for increasing surveillance data coverage and ILI care-seeking behavior, are displayed. The national early warning and
retrospective classification periods are overlaid in green and black, respectively. b The normalized relative risk of adult ILI to child ILI rates (ρs(t)), a
proxy of age-specific disease burden, follows a regular seasonal pattern during the U.S. Thanksgiving and winter holiday periods, and diverges
during the typical epidemic growth periods of January and February (around weeks 2–7)
relationship with retrospective severity ρs,r (Additional
file 1: Figure S9). Proportion of H3 subtype circulation had
a weak positive relationship (Additional file 1: Figure S10)
while a proxy of vaccine match had a negative relationship
with retrospective severity ρs,r (Additional file 1: Figure
S11).
Next, we repeated this analysis where ILINet, the
traditional ILI surveillance system maintained by the
CDC, was used instead of medical claims data to





did not appear to have a lin-





had a strong positive
relationship with βs (Pearson’s R = 0.64, p-value =
0.01) (Additional file 1: Figure S13), and that the ret-
rospective indexes for ILINet and the medical claims
had a strong positive relationship to each other (Pear-
son’s R = 0.78, p-value = 0.02) (Additional file 1:
Figure S14).
Fig. 3 Retrospective and early warning severity indexes compared to the benchmark. a Retrospective severity (ρs,r ) has a positive relationship with
the benchmark (R = 0.71, p-value = 0.05). b Early warning severity (ρs,w ) has a positive relationship with the benchmark (R = 0.59, p-value = 0.16).
The 2003–04 season was removed because it was an early flu season and the early warning period occurred after the retrospective period. Point
color corresponds to qualitatively-assigned severity category, where red is severe, yellow is moderate, and blue is mild
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State-level severity patterns and sentinels
We examined spatial severity patterns by calculating ret-
rospective and early warning indexes from age-specific ILI
rates at the state-level (based on the medical claims data).
Regardless of national retrospective severity (ρs,r), state-
level retrospective severity (ρs,r(τ )) could range frommild
to severe in a single season (Fig. 4a). Across the eight
study seasons, the adjacent Mid-Atlantic states of Virginia
and North Carolina may have experienced more severe
seasons than national ρs,r (75th percentile of state devia-
tion was above zero), and other adjacent Mid-Atlantic and
Midwestern states like Ohio, Pennsylvania, Florida, South
Carolina, and Maryland may have experienced somewhat
more severe seasons (70th percentile of state deviation
was above zero) (Fig. 4b). No state was highlighted for
experiencing milder flu seasons than the rest of the U.S.,
but western states had the lowest median ρs,r(τ ) indexes
across the study period (Additional file 1: Figure S12).
In a separate analysis, we explored whether “sentinel”
states, where early warning (ρs,w(τ )) was strongly corre-
lated with national retrospective severity (ρs,r), could be
identified. In Fig. 4c, we examined correlation coefficients
between ρs,w(τ ) and ρs,r among the 36 states with data
available for the seven study seasons (excludes the early
2003–04 season). Illinois and Virginia had early warning
indexes ρs,w(τ ) with strong positive correlations with ρs,r
(Pearson’s R = 0.82, 0.72; p-values = 0.01, 0.04, respec-
tively), while Colorado and Maine had a strong negative
correlationwith ρs,r (Pearson’s R= −0.80,−0.71, p-value=
0.02, 0.03, respectively).
Fig. 4 State-level patterns of seasonal influenza severity. a State retrospective severity (ρs,r(τ )) may range from mild to severe in a single season
regardless of the national retrospective severity index (ρs,r ). The 2007–08 (left) and 2008–09 (right) seasons, where ρs,r values were 16 and -9
respectively, are displayed. States in white did not have sufficient data to calculate a retrospective severity index. b Deviation between state (ρs,r(τ ))
and national retrospective severity (ρs,r ) across the eight study seasons was used to identify states that tend to experience more severe flu seasons
than other states. The 75th and 70th percentiles exceeded zero for red and orange highlighted states, respectively. c Pearson’s R correlation
coefficients (Ho : R = 0) between state early warning (ρs,w(τ )) and national retrospective (ρs,r ) classifications were used to suggest possible ‘sentinel’
states. Only coefficients for Illinois, Virginia, Colorado and Maine had p-values below 0.05. States in white did not have enough data to calculate at
least one of the two metrics for at least one study season
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Discussion
In this study, we have developed a composite indica-
tor that synthesizes different influenza data streams to
provide a quantitative benchmark of seasonal influenza
severity. We have also developed a novel severity index
based on age-related patterns of influenza-like illness that
can be used in both retrospective and early warning con-
texts. Motivated by our finding that adult ILI visits were
highly correlated with traditional measures of severity
like hospitalization and deaths, we developed a proxy for
influenza severity based on the ratio of ILI risk among
adults relative to that among children. As school-aged
children and adults are at the lowest risk for seasonal
influenza complications and death [26], our metric seeks
to measure signals of severity indirectly through popu-
lations that are well-represented in influenza case data
and well-connected to high-risk populations. The retro-
spective severity index had a positive correlation with the
benchmark, while the early warning index tended to err
conservatively from the standpoint of public health (i.e.,
early warning signals predicted more severe seasons than
occurred).
We constructed the composite severity benchmark to
synthesize publicly available influenza surveillance data
in the United States, and have shown that it agrees with
epidemiological understanding of historical CDC reports
of past influenza seasons. The benchmark thus captures
multiple facets of severity in composite form and fills a
gap in the current literature where quantitative ground
truth measures of population-level influenza severity are
absent. With additional data availability, future applica-
tions of the benchmark may add weights to contributing
data streams or apply alternative normalization methods
according to researcher or practitioner needs. Despite its
contribution to public health, this measure remains lim-
ited by its contributing data sources: these data streams
are not available in real-time, their data collection meth-
ods and definitions may change substantially across sea-
sons, and they are not readily collected at different spatial
scales or in different countries.
Our novel relative risk-based severity indexes based on
ILI age patterns aim to address the limitations of tra-
ditional severity measures. The retrospective index may
inform public health systems evaluations and enable his-
torical analysis of severe season attributes, which will
improve our understanding of influenza disease ecology.
In relation to existing severity measures, this index can
be used with a single data stream, and a source of data
(i.e., ILI) that is commonly collected in routine influenza
surveillance in many countries and at local departments
of health. The performances of our early warning index
remain modest, perhaps owing to the limited number of
seasons available for study. In theory, however, this or an
improved early warning index, determined 9–12 weeks
before the typical epidemic peak, may enable clinicians
to make informed decisions about patient diagnosis and
treatment strategies, and help hospitals to plan staffing
and supply logistics during an outbreak. Individual health-
related behaviors may change during an epidemic as
a result of health communication campaigns regarding
pharmaceutical [27] and behavioral [28, 29] interventions;
in pursuit of these goals, the early warning index presents
a novel attempt at real-time severity estimation. To make
the use of our metrics more intuitive and to provide an
example of how they may be used in an operational con-
text, we map the retrospective severity index to functional
indicators of influenza burden, including peak ILI, hos-
pitalization, and mortality rate in Fig. 5. (See Additional
file 1: SM section S7 for the calculation of operational
indicators).
The extension of our index to state-level patterns high-
lights how scalable severity metrics have the potential
to improve the observation of broader epidemiological
trends and forge new directions (e.g., spatial signals of
early warning) to inform public health preparedness. The
low data requirements of the relative risk-based indexes
enable continued future study over longer time periods,
which may help elucidate the mechanisms that drive spa-
tial variation in severity within individual seasons. Addi-
tional validation of state-level severity indexes is needed,
but the future identification of robust state sentinels could
improve multi-scale planning and coordination efforts
months before resources are widely demanded.
Instead of focusing on the elderly and young children
as traditional high-risk groups [30], our retrospective and
early warning indexes look for indirect signals of sever-
ity using the disease dynamics of ‘healthier’ populations.
Measurement of ILI among high-risk groups at outpa-
tient facilities may be unreliable, as those groups may be
seeking care at hospitals for severe pathology. Instead, we
use the more reliable signals provided by measurement
of ILI among working adults and school-age children.
We posit that school-aged children experience substan-
tial flu morbidity every season because they have high
numbers of potential disease-causing contacts [24, 31, 32]
and greater susceptibility due to limited prior exposure to
influenza. We hypothesize that adults have fewer contacts
and greater prior exposure than children, so they experi-
ence high flu activity only when the flu season is severe,
regardless if the cause is strain novelty, higher transmis-
sibility, greater virulence, or some combination of factors.
High connectivity between adults and other age groups
[24] and the role of adults in seeding new regions [33, 34]
may underlie our observation that seasons with high bur-
den in adult populations tend to be severe for the entire
population. In demonstrating the potential of this met-
ric, we call for the continued collection of age-specific
ILI data and additional research on the development of
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Fig. 5 Translation of retrospective severity to operational indicators of the burden of influenza. The retrospective severity index (ρs,r ) may be
mapped to historical data on cumulative confirmed influenza-related hospitalizations per 100,000, peak week outpatient visits due to ILI (ILINet), and
seasonal excess P&I mortality rates per 100,000 in order to inform decision makers about the expected range of disease burden in a given season.
Error bars represent the standard deviation in state-level variation of the excess P&I mortality rate, and bar color represents a milder to more severe
retrospective severity index value (dark blue to dark red)
thresholds to define and differentiate mild from severe
seasons.
Further work is needed to improve severity index signal
detection in the early warning period, and extra cau-
tion should be taken when making decisions based on
the early warning index. This period sometimes experi-
ences low influenza circulation, thus allowing pathogens
like respiratory syncytial virus (RSV) and Haemophilus
influenzae to confound the ILI age dynamics used in our
index [35]; however, we note that low circulation is rare
in our study period (Additional file 1: Table S3). Addition-
ally, the fixed nature of the early warning period limits its
utility for early-peaking flu seasons (e.g., 2003–04). Future
research should explore methods to represent uncertainty
in severity assessments; action upon incorrect predictions
could lead to overburdening the health care system or
the inefficient use of resources, and a mismatch in expec-
tations and reality could result in a loss of public trust
in public health agencies. Moreover, the early warning
index for ILINet surveillance did not perform well; this
may be explained by ILINet’s smaller sample size (roughly
1,900 providers submitted weekly reports in 2013–14 to
ILINet, while over 400,000 physicians reported to the
medical claims data in 2008–09) and narrower syndromic
definition of flu compared to the medical claims data,
both of which could limit the detection and classifica-
tion of influenza activity during the early warning period
(Additional file 1: Figure S13). Nevertheless, our obser-
vations of ILI age dynamics in this early warning period
(around weeks 49–52) lead us to hypothesize that the pre-
dictable age dynamic shifts in the abutting Thanksgiving
and winter holidays, which may be due to reduced contact
rates, create an insulated ‘severity testbed’ for improved
signal detection during these weeks. Future research on
holiday age dynamics and early flu seasons with dif-
ferent ILI surveillance systems may in fact reveal that
the early warning index is limited to use in the United
States.
The relative risk-based severity indexes are limited in
their detection capabilities for influenza pandemics. Pan-
demic events are characterized by different distributions
of age risk, which may alter the severity classifications
provided by our index; an initial pandemic wave may be
dominated by morbidity among school-aged children, and
empirical and modeling studies suggest that adults are
more likely to become infected in the season following a
pandemic [5, 36–39]. Moreover, there appears to be an
accumulation of heterosubtypic immunity for pandemic
strains with age [40]. Our index would not capture severity
in the first and second waves of pandemic virus circula-
tion, which is why we exclude the 2009–10 season from
our analysis, and unstable age dynamics in post-pandemic
seasons may explain poor performance of recent seasons
in the ILINet analyses (Additional file 1: Figure S13c-d).
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Our novel severity index relies on real-time age-specific
medical claims data for ILI, which does not appear to have
the disadvantages of flu-related ‘big data’ sources [20, 41].
Traditional ILI surveillance (eg. ILINet) also provides real-
time age-specific data, but the medical claims database
represents a more obligatory form of provider report-
ing, captures ILI activity at least as well as traditional
surveillance, and provides higher coverage, greater spa-
tial resolution, and finer age-specific disease information
due to its administrative purpose [20]. Medical claims and
ILINet data are both subject to physician biases regard-
ing the demographics and seasonality of influenza and
doctor’s office closures. They also have healthcare-seeking
behavior biases; school-aged children have higher rates of
healthcare-seeking behavior for ILI than adults (approxi-
mately 1.1 to 1.4 times higher) [42–44], which we consider
in the construction of our index (See Additional file 1: SM
section S2). Additional studies on disparities in insurance
and access to care, especially in consideration of ongoing
changes to the U.S. health care system, are needed to bet-
ter quantify biases in medical claims data as compared to
other flu surveillance systems.
Conclusions
Traditional measures of seasonal influenza severity are
limited by their need for multiple data streams and the
lack of accurate hospitalization and mortality data in
real-time. In our study, relative disease burden among
adults and children is proposed as the basis for a novel
population-level severity index with retrospective and
early warning classification periods, and the index is
applied to influenza-like illness data in the United States
across multiple seasons and spatial scales. By correctly
identifying the two most severe influenza seasons in
the study period, this work represents proof of concept
that influenza age dynamics may provide epidemiologi-
cal understanding beyond surveillance data at face value,
and our approach may be used by physicians, hospital
administrators, and policy makers to make real-time deci-
sions about clinical, logistical, and strategic responses to
a seasonal influenza outbreak. While further study of the
novel severity metrics is warranted, we recommend that
researchers and practitioners consider the use of compos-
ite or ILI-based metrics in addition to traditional sever-
ity measures for improved epidemiological understanding
and situational awareness. Our research raises new ques-
tions about causal severity mechanisms; future analyses
should disambiguate the age patterns characterized in our
study as a harbinger or result of population-level severity,
examine the hypothesis that holiday contacts seed broader
infection in different age groups [45] or new locations,
and examine different regional subtype circulation, pre-
existing immunity, age distributions, or vaccine coverage
rates as mechanisms for spatial variation in severity.
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